2nd-Feb-2012 10:05
Source: BSE
Wockhardt- Q3 results on Feb 13, 2012
Wockhardt Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 13, 2012, inter-alia to consider and approve the Un-audited Financial results of the Com...
10th-Jan-2012 11:43
Source: NSE
Wockhardt Limited
Wockhardt Limited has informed the Exchange regarding a press release dated January 10, 2012, titled "Wockhardt launches generic version of Rhinitis drug Flonase nasal spray".
18th-Nov-2011 14:26
Source: NSE
Wockhardt Limited
Wockhardt Limited has informed the Exchange that the Compensation Committee of the Board at its meeting held on November 12, 2011, inter alia, has approved the Grant of 1,540,000 Stock Options convert...
12th-Nov-2011 16:10
Source: NSE
Wockhardt Limited-ESOPs/ESOS
Wockhardt Limited has informed the Exchange that the Compensation Committee of the Board at its meeting held on November 12, 2011 has approved the Grant of 1,540,000 Stock Options convertible into 1,5...
12th-Nov-2011 16:02
Source: NSE
Wockhardt Limited-Financial Result Updates
Wockhardt Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended September 30,2011.
12th-Nov-2011 13:54
Source: BSE
Wockhardt- Outcome of Board Meeting
Wockhardt Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 12, 2011, inter alia, has approved the Grant of 1,540,000 Stock Options convertible into 1,540...
3rd-Nov-2011 09:20
Source: BSE
Wockhardt- Q2 results on Nov 12, 2011
Wockhardt Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 12, 2011, inter-alia to consider and approve the Un-audited Financial results of the Com...
13th-Sep-2011 12:03
Source: NSE
Wockhardt Limited
Wockhardt Limited has informed the Exchange regarding the Outcome of the Annual General Meeting of the Company held on September 12, 2011.